The Impact of COVID-19 is included in Biologics Contract Development Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Biologics Contract Development Trends and Forecast
The future of the global biologics contract development market looks promising with opportunities in the oncology, immunological disorder, cardiovascular disorder, and hematological disorder markets. The global biologics contract development market is expected to reach an estimated $40.9 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers for this market are rising number of drug development procedures by pharmaceutical companies, growing adoption of advanced technologies, and favorable environment for clinical trials in the developing countries.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Biologics Contract Development by Segment
The study includes a forecast for the global biologics contract development by source, product service, disease indication, and region.
Biologics Contract Development Market by Source [Shipment Analysis by Value from 2018 to 2030]:
• Microbial
• Mammalian
• Others
Biologics Contract Development Market by Product Service [Shipment Analysis by Value from 2018 to 2030]:
• Cell Line Development
• Process Development
• Others
Biologics Contract Development Market by Disease Indication [Shipment Analysis by Value from 2018 to 2030]:
• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others
Biologics Contract Development Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Biologics Contract Development Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biologics contract development companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biologics contract development companies profiled in this report include-
• WuXi Biologics
• Abzena
• Fujifilm Diosynth Biotechnologies
• KBI Biopharma
• AGC Biologics
• Thermo Fisher Scientific
• Curia Global
• Genscript
• Bionova Scientific
• BioXcellence
Biologics Contract Development Market Insights
Lucintel forecasts that mammalian will remain the larger segment over the forecast period due to increasing adoption of mammalian cells for protein expression, which provides a major advantage by developing mammalian proteins with correct post-translational modifications that delivers a native structure.
Within this market, oncology will remain the largest segment due to growing demand for therapy, which encourages more investments in research and development and outsourcing.
North America will remain the largest region over the forecast period due to growing R&D investments, rising demand of clinical trials, and presence of major players in the region.
Features of the Global Biologics Contract Development Market
Market Size Estimates: Biologics contract development market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Biologics contract development market size by source, product service, disease indication, and region in terms of value ($B).
Regional Analysis: Biologics contract development market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different sources, product services, disease indication, and regions for the biologics contract development market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biologics contract development market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the biologics contract development market size?
Answer: The global biologics contract development market is expected to reach an estimated $40.9 billion by 2030.
Q2. What is the growth forecast for biologics contract development market?
Answer: The global biologics contract development market is expected to grow with a CAGR of 11.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the biologics contract development market?
Answer: The major drivers for this market are rising number of drug development procedures by pharmaceutical companies, growing adoption of advanced technologies, and favorable environment for clinical trials in the developing countries.
Q4. What are the major segments for biologics contract development market?
Answer: The future of the biologics contract development market looks promising with opportunities in the oncology, immunological disorder, cardiovascular disorder, and hematological disorder markets.
Q5. Who are the key biologics contract development market companies?
Answer: Some of the key biologics contract development companies are as follows:
• WuXi Biologics
• Abzena
• Fujifilm Diosynth Biotechnologies
• KBI Biopharma
• AGC Biologics
• Thermo Fisher Scientific
• Curia Global
• Genscript
• Bionova Scientific
• BioXcellence
Q6. Which biologics contract development market segment will be the largest in future?
Answer: Lucintel forecasts that mammalian will remain the larger segment over the forecast period due to increasing adoption of mammalian cells for protein expression, which provides a major advantage by developing mammalian proteins with correct post-translational modifications that delivers a native structure.
Q7. In biologics contract development market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing R&D investments, rising demand of clinical trials, and presence of major players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the biologics contract development market by source (microbial, mammalian, and others), product service (cell line development, process development, and others), disease indication (oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Biologics Contract Development Market, Biologics Contract Development Market Size, Biologics Contract Development Market Growth, Biologics Contract Development Market Analysis, Biologics Contract Development Market Report, Biologics Contract Development Market Share, Biologics Contract Development Market Trends, Biologics Contract Development Market Forecast, Biologics Contract Development Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Biologics Contract Development Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Biologics Contract Development Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Biologics Contract Development Market by Source
3.3.1: Microbial
3.3.2: Mammalian
3.3.3: Others
3.4: Global Biologics Contract Development Market by Product Service
3.4.1: Cell Line Development
3.4.2: Process Development
3.4.3: Others
3.5: Global Biologics Contract Development Market by Disease Indication
3.5.1: Oncology
3.5.2: Immunological Disorders
3.5.3: Cardiovascular Disorders
3.5.4: Hematological Disorders
3.5.5: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Biologics Contract Development Market by Region
4.2: North American Biologics Contract Development Market
4.2.2: North American Biologics Contract Development Market by Disease Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others
4.3: European Biologics Contract Development Market
4.3.1: European Biologics Contract Development Market by Source: Microbial, Mammalian, and Others
4.3.2: European Biologics Contract Development Market by Disease Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others
4.4: APAC Biologics Contract Development Market
4.4.1: APAC Biologics Contract Development Market by Source: Microbial, Mammalian, and Others
4.4.2: APAC Biologics Contract Development Market by Disease Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others
4.5: ROW Biologics Contract Development Market
4.5.1: ROW Biologics Contract Development Market by Source: Microbial, Mammalian, and Others
4.5.2: ROW Biologics Contract Development Market by Disease Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Biologics Contract Development Market by Source
6.1.2: Growth Opportunities for the Global Biologics Contract Development Market by Product Service
6.1.3: Growth Opportunities for the Global Biologics Contract Development Market by Disease Indication
6.1.4: Growth Opportunities for the Global Biologics Contract Development Market by Region
6.2: Emerging Trends in the Global Biologics Contract Development Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Biologics Contract Development Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biologics Contract Development Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: WuXi Biologics
7.2: Abzena
7.3: Fujifilm Diosynth Biotechnologies
7.4: KBI Biopharma
7.5: AGC Biologics
7.6: Thermo Fisher Scientific
7.7: Curia Global
7.8: Genscript
7.9: Bionova Scientific
7.10: BioXcellence
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Biologics Contract Development Market Report.